Wellbutrin (bupropion) is primarily used to treat major depressive disorder. It’s also prescribed under different brand names for smoking cessation and seasonal depression, and it’s frequently used off-label for ADHD. What sets it apart from most antidepressants is its unique mechanism: it works on dopamine and norepinephrine rather than serotonin, which gives it a distinct side effect profile that many people prefer.
Major Depressive Disorder
The FDA approved Wellbutrin specifically for major depressive disorder, and this remains its primary use. It works by blocking the reuptake of two brain chemicals, dopamine and norepinephrine, allowing them to stay active in the brain longer. This is fundamentally different from SSRIs like sertraline (Zoloft) or fluoxetine (Prozac), which target serotonin instead. Research confirms that bupropion has essentially no meaningful effect on serotonin at any tested dose.
This distinction matters in practice. Because Wellbutrin leaves serotonin alone, it carries the lowest rate of sexual side effects among antidepressants. SSRIs are the most likely to cause problems like decreased libido, difficulty with arousal, or trouble reaching orgasm. In fact, doctors sometimes add Wellbutrin to an existing SSRI regimen specifically to counteract those sexual side effects. For people who’ve tried an SSRI and found the sexual side effects intolerable, Wellbutrin is often the next option considered.
Wellbutrin also tends to be more activating than sedating, which can help with the fatigue and low motivation that often accompany depression. Some people experience a mild appetite-suppressing effect, another contrast with SSRIs, which can cause weight gain.
Smoking Cessation
The same active ingredient, bupropion, is sold under the brand name Zyban for smoking cessation. Wellbutrin itself isn’t approved for this purpose, but it contains the identical drug. Clinical trial data shows that bupropion roughly doubles the odds of quitting smoking long-term compared to placebo. The dopamine-boosting effect likely helps by reducing nicotine cravings and easing withdrawal symptoms, since nicotine itself acts on the brain’s dopamine system.
Treatment for smoking cessation typically starts one to two weeks before the planned quit date, giving the medication time to reach effective levels in the body. If your doctor prescribes Wellbutrin for depression and you also smoke, both conditions may benefit from the same prescription.
Seasonal Affective Disorder
Wellbutrin XL is the only antidepressant with FDA approval specifically for preventing seasonal affective disorder (SAD), the pattern of depression that returns every fall and winter. Three large clinical trials involving over 1,000 patients showed that starting bupropion XL in early autumn, while patients were still feeling well, could prevent depressive episodes from developing as the days shortened. Patients took 150 to 300 mg daily through the fall and winter months, then tapered off in spring.
This preventive approach is unusual. Rather than waiting for symptoms to appear and then treating them, the strategy is to begin medication before the seasonal pattern kicks in.
Off-Label Use for ADHD
Wellbutrin is commonly prescribed off-label for attention-deficit/hyperactivity disorder, particularly in adults. Clinical guidelines list bupropion as a third-line option after stimulant medications and atomoxetine. A large comparative analysis found that bupropion was modestly effective for adult ADHD, though not as potent as amphetamine-based medications.
Where bupropion really earns its place in ADHD treatment is when other conditions overlap. It’s considered especially useful when a person has ADHD alongside depression, nicotine dependence, or a history of stimulant misuse, since prescribing a stimulant in that last scenario raises obvious concerns. Effects on ADHD symptoms take several weeks to appear, longer than the near-immediate response most people notice with stimulants.
Three Formulations, One Drug
Wellbutrin comes in three formulations that release the drug at different speeds. The extended-release version (XL) is the preferred option for most people. It’s taken once daily, typically in the morning, and delivers the most stable blood levels throughout the day. The sustained-release version (SR) is taken twice daily with at least eight hours between doses. The original immediate-release (IR) version requires three to four doses per day, which makes it impractical for most people. It’s rarely prescribed now except when cost is a major factor or when very precise dose adjustments are needed.
The formulation difference isn’t just about convenience. The XL version produces the lowest peak drug concentrations, which may reduce the risk of side effects, particularly seizures. The IR version produces higher, sharper peaks in the bloodstream and carries a somewhat higher seizure risk as a result.
Seizure Risk and Who Should Avoid It
The most significant safety concern with Wellbutrin is a dose-dependent seizure risk. At standard doses up to 300 mg per day of the sustained-release formulation, the risk is about 0.1%, or 1 in 1,000 people. That risk climbs to roughly 0.4% at doses between 300 and 450 mg per day with the immediate-release version, and increases almost tenfold between 450 and 600 mg per day. This is why there’s a firm dosage ceiling.
Several groups of people should not take Wellbutrin at all. It’s contraindicated for anyone with a seizure disorder, and for anyone with a current or past diagnosis of bulimia or anorexia nervosa, because a higher incidence of seizures was observed in patients with eating disorders during clinical trials. People who are abruptly stopping alcohol or sedatives (including benzodiazepines) also face elevated seizure risk and should not start bupropion during that withdrawal period.
Other factors that raise seizure risk include a history of head trauma, brain tumors, severe liver disease, heavy alcohol use, diabetes treated with insulin or oral medications, and taking other drugs that lower the seizure threshold. If any of these apply to you, your prescriber needs to weigh the risks carefully before choosing this medication.
How It Compares to Other Antidepressants
Wellbutrin occupies a unique niche. It’s the only widely prescribed antidepressant that works primarily through dopamine and norepinephrine without touching serotonin. This gives it a set of advantages and trade-offs that make it a better fit for some people and a worse fit for others.
On the advantage side: lower rates of sexual dysfunction, less weight gain, less sedation, and potential benefits for focus and motivation. On the other side: it can increase anxiety in some people (especially early in treatment), it doesn’t help with the anxiety disorders that SSRIs are also approved for, and the seizure risk requires more careful screening. It also won’t cause the emotional blunting that some people report with SSRIs, which can be a deciding factor for people who’ve felt “flat” on serotonin-based medications.
For people whose depression involves prominent fatigue, difficulty concentrating, or low motivation, Wellbutrin’s activating profile can be a particularly good match. For those whose depression is dominated by anxiety, insomnia, or agitation, an SSRI or another class of antidepressant may be more appropriate.